PepGen’s Low-Dose DM1 Data Falls Flat: Minimal Splicing Correction and No Clear Functional Benefit
PepGen’s latest low-dose (5 mg/kg) DM1 data shows minimal splicing correction and almost no functional improvement over placebo.
NOTRELOAD AI
Instacart Gets Upgraded: AI Could Be a Big Win for the Stock
Jefferies analyst upgrades Instacart from Hold to Buy with a $45 price target.
Palo Alto Networks Shares Surge Following CEO’s $10 Million Insider Buy
Palo Alto Networks shares rose on Monday after CEO Nikesh Arora purchased nearly $10 million worth of stock on Friday’s dip.
Optical Stocks Slammed as Samsung Jumps into Silicon Photonics
Optical stocks plunged as Samsung officially announced its entry into the silicon photonics market with 224Gbps tech and ambitious AI plans.
Alaska Air Slashes Q1 Profit Forecast as Iran War Fuels Record Fuel Costs
Alaska Air now expects a deeper Q1 2026 adjusted loss of $1.50–$2 per share due to surging fuel prices and weaker demand in Mexico & Hawaii.
Alumis Stock Crashes in Classic “Sell the News” After Strong Phase 3 Psoriasis Data
Alumis shares plunged after strong Phase 3 psoriasis data for envudeucitinib. HC Wainwright cuts price target to $25 citing rising competition.